Actinium Pharmaceuticals reported $40.16M in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
AbbVie USD 135.12B 1.35B Jun/2026
Actinium Pharmaceuticals USD 40.16M 5.28M Jun/2026
Amgen USD 95.64B 3.14B Jun/2026
Bioline Rx USD 38.8M 2.11M Mar/2026
Capricor Therapeutics USD 368.74M 42.45M Jun/2026
Pfizer USD 201.13B 6.49B Jun/2026